HuGen

Hu.Gen is an innovative biotechnology startup based in Milan, Italy, focused on molecular diagnostics and targeted therapy. The company aims to deepen understanding of genomic mechanisms and translate that knowledge into personalized diagnostic and therapeutic solutions. Its team combines professional expertise and academic experience with innovative strategies, applications, and technologies to support translational research in human diseases.

Hu.Gen provides genome and transcriptome analysis using next-generation sequencing (NGS) platforms, alongside research into personalized molecular-targeted therapeutic activity. Its work spans DNA, RNA, and proteins, and its services also include lead compound design, consultancy, and training. Through this combination of analytical services and biotechnology solutions, Hu.Gen supports research and development in areas where molecular insights can inform diagnostic and therapeutic approaches. The company presents its services to researchers and organizations seeking expertise in molecular analysis, biotechnology, and personalized target therapy. Hu.Gen also shares updates on sector developments, recent research, and emerging technologies through its newsletter.